<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Controversy exists regarding the influence of <z:hpo ids='HP_0001653'>mitral regurgitation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>) on thromboembolic risk in patients with <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to investigate retrospectively a reduction of risk for <z:hpo ids='HP_0001297'>stroke</z:hpo> due to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> in <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> and to evaluate the effectiveness of low-intensity anticoagulation therapy </plain></SENT>
<SENT sid="2" pm="."><plain>In 313 patients with <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>, transthoracic echocardiography was performed and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> was graded </plain></SENT>
<SENT sid="3" pm="."><plain>Between the groups with no or mild <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> (n = 209) and with moderate or severe <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> (n = 104), age, sex, treatment, history of <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:mp ids='MP_0001548'>hyperlipemia</z:mp> and <z:hpo ids='HP_0001718'>mitral stenosis</z:hpo>, and previous <z:hpo ids='HP_0001297'>stroke</z:hpo> were compared </plain></SENT>
<SENT sid="4" pm="."><plain>No significant differences in clinical characteristics, treatment, or history were observed between the two groups </plain></SENT>
<SENT sid="5" pm="."><plain>The incidence of <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> was significantly higher in the group with no <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> (48 patients [23%]) than in the group with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> (14 patients [13%], p &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>In the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> group, previous <z:hpo ids='HP_0001297'>stroke</z:hpo> was frequently observed in patients without <z:chebi fb="8" ids="10033">warfarin</z:chebi> treatment (11 of 51 patients) compared with patients with low-dose <z:chebi fb="8" ids="10033">warfarin</z:chebi> treatment (international normalized ratio of 1.6-1.8) (3 of 53 patients, p &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Consequently, the thromboembolic event was markedly prevented by low-dose <z:chebi fb="8" ids="10033">warfarin</z:chebi> treatment </plain></SENT>
</text></document>